China backers help bankroll a $100M mega-round as an influential antibody engineer readies trials
Kymab turned to some marquee names in the UK and the US for the money needed to establish the company as a high-profile player in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
